DATE OF BIRTHGold medal in surgery-1993, SRMC, India. Gold medal in anatomy-1990, SRMC, India. Honours in Anatomy, Physiology and Biochemistry In the University and College examinations

CURRICULUM VITAE

Dr. N. RAGAVAN

MS (Gen Surg), FRCSEd (Surgery in General)

PGC in Teaching and Learning

MD(Uro-Oncology), FRCS(Urology)

Fellow In Minimally Invasive Urology

(Robotics and Laparoscopy)

Senior Consultant Urological Surgeon & UroOncologist

(Laparoscopy & Robotics)

Apollo Hospitals, Chennai

CV of N. Ragavan MS(Gen Surg), FRCSEd, PGCTLCP, MD(Uro-Oncology), FRCS(Urol)

2

PERSONAL DETAILS NAME Dr. N. RAGAVAN

PHONE +919840014421

Email [email protected]

ACADEMIC QUALIFICATIONS

Degree College / University

Month and Year

MBBS

Sri Ramachandra Medical College and Research Institute (SRMC) Madras, India

January 1995

MS (Gen Surgery)

Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, India

December 1998

FRCS

Royal College of Surgeons of Edinburgh

February 1999

Postgraduate Certificate in Teaching and Learning in Clinical Practice

Edge Hill College, Lancaster University

May 2005

MD Lancaster University May 2006

FRCS (Urol) Royal College of Surgeons May 2009

Fellowship Minimally Invasive Urology (Robotics and Laparoscopy)

University of Leipzig

April 2011 &Sep 2012

CERTIFICATION GMC&CCT (Urol) 5208047 (Full)

USI R275 ASU R005 TMC 55311


3

AWARDS AND HONOURS

Best of BAUS – Poster no 90 , Manchester 2006

Brian Booth Research Prize - Rosemere Cancer Foundation, 2005

Best Poster award – Poster session 37 at EAU, 2005

Best Presentation prize - North West Trainee’s Research Meeting, 2004

Best young Scientist award -1993-94, State Medical Council for Science and Technology.

Gold medal in surgery -1993, SRMC, India.

Gold medal in anatomy -1990, SRMC, India.

Honours in Anatomy, Physiology and Biochemistry In the University and College examinations -1990.

Honours in Ophthalmology, Microbiology and Community Medicine In the University Examinations -1992.

GRANTS

Grant for fellowship from Prostate UK

Norman Gibbon Travelling Fellowship

Seedcorn funding by the research directorate of Lancashire Teaching Hospitals NHS Trust

Joint applicant with Dr A Hindley for Rosemere Cancer Foundation funding for my research project.


4

CLINICAL EXPERIENCE

Post Hospital Period Consultants

Senior Consultant Urological Surgeon, Uro Oncologist

Apollo Hospitals Chennai

Sept 18 onwards

Independent

Senior Consultant Urological Surgeon, Uro Oncologist

Gleneagles Global Hospitals, Chennai

Nov 17- August 18

Independent

Consultant Urological Surgeon, Uro Oncologist

Apollo Hospitals, Chennai

Jan 13 Nov 17

Independent

Consultant Urological Surgeon And Uro Oncologist

Bradford Royal Infirmary

Aug11 Dec 12

Independent

Consultant Urological Surgeon And Uro Oncologist

Glan Clwyd Hospital

April11 to July 11

Independent

Fellowship in Laparoscopy and Minimally Invasive Urology

University of Leipzig

Jan 11 to March 11

Prof. Stolzenburg

Subspeciality in UroOncology and Laparoscopy

Wirral University Hospital

Feb 10 to Dec10

Mr Parr Mr Stephenson Mr Kumar

Subspeciality in UroOncology and Laparoscopy

Royal Liverpool Hospital

May 09 to Jan 10

Mr. Cornford

May 2009 FRCS ( Urol)

Specialist Registrar Urology (UroOncology / Laparoscopy)


Feb 09 to Jan 10

Mr. Cornford

Specialist Registrar Urology (General/ Reconstruction/ Stones / Andrology)

Aintree Hospitals NHS Trust

Oct 07 to Jan 09

Mr Machin Mr Williamson Mr Baird

Specialist Registrar Urology (General / Stones/ Oncology/ Laparoscopy/ Incontinence)

Leighton Hospital Oct 06 to Sept 07

Mr. Irwin Mr Stubington Mr Javle

Specialist Registrar Urology (Andrology/ Incontinence)


April 06 to Sept 06

Mr. Desmond


5

Specialist Registrar Pediatric Urology

Royal Liverpool Children’s Hospital

Oct 05 to March 06

Mr. Kenny Miss.McAndrew

Specialist Registrar Urology (General/ Oncology)


July 05 to Sept 05

Mr. Cornford

Research Registrar Uro Oncology

Royal Preston Hospital, Preston

July 03 to June 05

Mr.Matanhelia Dr. Hindley

Hospital Registrar, Urology

Royal Preston Hospital

Jan 03 to June 03

Mr. Watson Miss. Blades Mr. Matanhelia

Senior SHO Urology (Mid grade cover in Urology, UroOncology)

Royal Preston Hospital,

Aug 02 to Dec 02

Mr. Watson Miss. Blades Mr. Matanhelia

Senior SHO urology (SHO on call for Urology, UroOncology and Surgery)

Leighton Hospital Crewe

July 01 to Aug 02

Mr. Irwin Mr. Javle Mr. Stubington

SHO Gen Surgery

Caithness Hospital Scotland

Feb 01 to July 01

Mr. Fisher

Registrar Gen Surgery

JIPMER India

Jan 00 to Jan 01

Prof. Srinivasan

Registrar Gen Surgery

PGIMER India

Jan 99 to Jan00

Prof. Katariya

SHO surgical rotation (General surgery, A&E, Urology and Renal transplant, other specialties)

PGIMER India

Jan 96 to Jan 99

Prof. Katariya Prof. Bose Prof. Sharma

Post graduate trainee Surgery (Urology, Gen surgery, Orthopedics)

MKCG Hospital India

April 95 to Jan 96

Prof. Subudhi Dr. Subudhi

PRHO (Medicine, Surgery, Obs&Gyne, Community medicine)

SRMC Hospital India

Jan 94 to Jan 95


6

Experience in Urology I work as a consultant urological surgeon with special interest in uro-oncology. I regularly perform major uro-oncological procedures utilising the modalities (robotic , laparoscopic and open surgery as appropriate) include radical nephrectomy, nephroureterectomy, nephron sparing surgery (partial nephrectomy), caval thrombus excision, radical prostatectomy, radical cystectomy with ileal diversion( including Intracorporeal), anterior pelvic exenteration, pelvic and retroperitoneal lymphadenectomy, neo-bladder reconstruction, penile cancer surgery ( glansectomy, partial , total amputation), Inguinal node dissection and testicular cancer surgery. I have substantiated my laparoscopic uro-oncology experience by completing laparoscopy and minimally invasive fellowship under Prof. Stolzenburg at University of Leipzig, Germany. I am performing Robotic surgery including radical prostatectomy robotic cystectomy and intracorporeal conduit, Robotic partial nephrectomy, RPLND, Nephroureterectomy , adrenelectomy , VVF repair and help gynaecologists during hysterectomy & sacrocolpopexy. Infact, I performed the first intracorporeal complete Nephroureterectomy at Chennai ( both upper and lower end), first Robotic RPLND for testicular Ca, Robotic Boari flap for uretric reconstruction & Extra Peritoneal Robotic Prostatectomy and Robotic Cystectomy + Intracorporeal Conduit , Intra corporeal Augumentation cystoplasty , Extraperitoneal segmental excision of ureter at Apollo Chennai..

I perform the full range of urological surgeries ( core urology) such as TURP , TURBT , Ureteroscopy , penoscrotal surgery However my area of interest is urooncology. My full experience since 2005 is available electronically. Prior to this, I have maintained a hand-written logbook. Experience in General surgery

I completed my postgraduate training from PGIMER, one of the premier institutes in India. I also worked a senior resident in PGIMER and in JIPMER. I gained invaluable experience in these institutions. I have performed appendicectomy, repair of hernia, cholecystectomy, ileostomy, colostomy, small and large bowel resection, perforation closure, thyroidectomy and mastectomy independently. I have assisted and performed (under supervision) in many major abdominal surgeries including pancreatectomy, oesophagectomy, abdominal perineal resection, hepatectomy and vascular procedures. I have maintained hand-written logbook of my experience from these institutions.


7

RESEARCH EXPERIENCE Thesis Title An analysis of hormone- or carcinogen-metabolising enzyme expression in human prostate in relation to susceptibility to adenocarcinoma and an epidemiological investigation of lifestyle risk factors Sections of the work have been presented in AACR (2004, 2005, 2006), UKEMS (2004), BPG (2004, 2006), URS (2005), EEMS (2005) and EAU (2006). I have published part of the work in Cancer Letters, Biophysical Journal, Prostate Cancer and Prostatic Diseases and Prostate

Thesis Projects “Inter- and Intra - individual differences in the gene expression of phase I and phase II enzymes in the normal prostate”

To investigate whether a differential expression profile in phase I/II genes might explain zone susceptibility to CaP, we obtained tissue sets consisting of PZ and transition zone (TZ) of prostate. Levels of CYP1B1 and NAT1 were distinctly higher in PZ. Immunohistochemistry confirmed the presence of CYP1B1 and NAT1 in the prostate. “Survey of the incidence of major ailments amongst female partners of men diagnosed with prostate cancer: a pilot study” A questionnaire study into the risk of common cancers in female partners of CaP males in NorthWest England was conducted. Rates for breast, colorectal or lung cancer among female partners were similar to estimates. However, observed rates for breast or lung cancers among previous female partnerss were significantly (p

0.001) elevated “IR spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell”

The IR spectral signature of PZ and TZ was obtained using Fourier- transform infrared (FTIR) micro-spectroscopy Following spectroscopic analysis, plotted clusters and their loadings curves highlighted marked spectral variation in the region

containing DNA/RNA bands (1,490-1,000 cm-1). TZ cells appeared to align more closely with CaP cells while exhibiting marked structural differences compared to PZ cells.

In conclusion, the prostate gland possesses the metabolic machinery to activate pro-carcinogens. It is likely that environmental and/or dietary factors play an important role in the aetiology of CaP.


8

Other Postgraduate projects “Economic consequences of Prostate and Bladder cancer in the UK” Method - Prospective analysis of the direct and indirect costs of the treatment of prostate and bladder cancer patients in one year (2001-02) at Royal Preston Hospital and for the UK using BAUS database. Direct costs are calculated on the basis of EAU guidelines and the indirect costs are calculated with the help of economics chart. The correlation of research investment to the cost of disease management was done. Results - Total costs for the treatment of prostate cancer were more than bladder cancer. However individual patients treatment cost was higher for bladder cancer. There was a substantial difference in the research investment for prostate cancer compared to bladder cancer. This has been published BJUI and a parts were presented at BPG, 2004 and EAU 2005. “A Randomised Controlled Trial comparing Lignocaine Peri-Prostatic Nerve Block (PPNB), Diclofenac suppository and both in Transrectal Ultrasound (TRUS) guided biopsy of prostate”

Method - Prospective randomised controlled trial with 55 patients in each group. This project was done at Leighton Hospital. Results - The patients in the combination group felt less pain during and after biopsy compared to the other groups. This study was presented in EAU 2003 and BPG 2004 and was published in J Urol “Efficacy of combined ESWL with percussion on lower pole stone clearance” Method - Prospective study done in 30 patients at Leighton hospital. Results - Initial results were promising in achieving good stone clearance by this combined method. “Effect of erythromycin and cisapride on gastric emptying of the vagally denervated intrathoracic stomach” (Part of MS dissertation) Method - Prospective randomised study of 19 post esophagectomy patients using radioisotope-labelled rice cakes to assess the empting of the denervated intrathoracic stomach was done at PGIMER, India. Results - Gastric emptying was significantly accelerated by cisapride.

Undergraduate project “Correlation study of BMI, Central obesity, Blood pressure and Metabolic disturbances in South Indian Population”

I was awarded the "Best young scientist in the state" Method -50 patients in each group were identified. Results -Hypertensive patients had higher incidence of hyperinsulinemia along with high body mass index.


9

ONGOING PROJECTS

Vitamin D3 levels in patients with urinary stones

Radical prostatectomy – Single surgeon experience

Radical prosatetcomy – Multi-institution experience

PI for Phase IV trial of Inj Degarelix in Indian population

Enhanced recovery after major urological surgery

PUBLICATIONS Published

Ragavan N, Dholakia K, Ramesh M, Stolzenburg JU. Extraperitoneal vs. transperitoneal robot-assisted laparoscopic radical prostatectomy-analysis of perioperative outcomes, a single surgeon's experience. J Robot Surg. 2018 Jul 19.

Shah P, Ragavan N, Bhat S, Dholakiya K. Case report: Robot-assisted laparoscopic excision of giant ganglioneuroma of the adrenal gland. J Robot Surg. 2017 Jul 26.

Primary Intrarenal Yolk Sac Tumour . N Ragavan, K Dholakia, S Annapurneswari. IJU 2017 ; 33;2; 167

Robot assisted Laparoscopic excision of Organ of Zuckerkandl . N Ragavan, NK Narayanan, Malavizhi Ramesh, YVC Reddy. J. Robotic surgery. 2016. Dec;10(4):373-374

Prostate Biopsy for elevated PSA – Indian Perspective .N. Ragavan IJMR June 2014

Feasibility of minimally invasive radical prostatectomy in prostate cancer patients with high prostate-specific antigen: feasibility and 1-year outcomes Do M, Ragavan N, Dietel A, Liatsikos E, Anderson C, McNeill A, Stolzenburg

JU. Int J Urol. 2012 Oct;19(10):923-7.

Comments on the extraperitoneal approach for standard laparoscopic radical prostatectomy: what is gained and what is lost. Liatsikos E, Kyriazis I, Kallidonis P, Do M, Haefner T, Dietel A, Holze S, Ragavan N, Stolzenburg JU. Prostate Cancer. 2011

Clinical outcomes of laparo-endoscopic single-site surgery radical nephrectomy .Stolzenburg JU, Kallidonis P, Ragavan N, Dietel A, Do M, Thi

PH, Till H, Liatsikos EN. World J Urol. 2012 Oct;30(5):589-96.


10

Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro-carcinogens to DNA-damaging metabolites. Martin FL, Patel II, Sozeri O, Singh PB, Ragavan N, Nicholson CM, Frei E, Meinl W, Glatt H, Phillips DH, Arlt VM. Prostate. 2010 Oct 1;70(14):1586-99.

“ High level of SOX9 in the prostate contributes to increased proliferation and can cooperate with PTEN loss to accelerate neoplasia formation” Martin K. Thomsen, Laurence Ambroisine, Sarah Wynn, Kathryn S Cheah, Christopher S. Foster, Gabrielle Fisher, Daniel M. Berney, Henrik Møller, Victor Reuter, Peter Scardino, Jack Cuzick, The Transatlantic Prostate Group, Narasimhan Ragavan, Paras B. Singh, Francis L. Martin, Christopher K. Butler, Colin S. Cooper and Amanda Swain

Cancer Res. 2010 Feb 1;70(3):979-87

“ Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study Paras B. Singh, Narasimhan Ragavan, Katherine M. Ashton, Prabir Basu, Sayeed M. Nadeem, Caroline M. Nicholson, R. K. Gopala Krishna, Shyam S. Matanhelia, and Francis L. Martin Asian J Androl. 2010 Mar;12(2):203-14

“Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience.” Singh PB, Nicholson CM, Ragavan N, Blades RA, Martin FL, Matanhelia SS.. BMC Urol. 2009 May 27;9(1):3.

“Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate” John K, Ragavan N, Pratt MM, Singh PB, Al-Buheissi S, Matanhelia SS,

Phillips DH, Poirier MC, Martin FL. Prostate. 2009;69(5):505-19

“Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to Guide Timing of Androgen Deprivation in Patients with T0-4 N0-2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891).” Ragavan N, Singh PB, Martin FL, Baird AD Eur Urol 2008;53:941-9.

“Re; The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. PB Singh, N Ragavan , FL Martin, SS

Matanhelia .BJU Int. 2009 Feb;103(4):553

“Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland.”

Noel EE*, Ragavan N*, Walsh MJ, James SY, Matanhelia SS, Nicholson


11

CM, Lu YJ, Martin FL. (*Joint first Authors) Prostate Cancer Prostatic Dis. 2008;11(2):173-80

“Identify the variables responsible for cluster formation in discriminant analysis of data derived from IR microspectroscopy of a biological sample” FL. Martin, MJ. German, E Wit, T Fearn, N Ragavan and HM. Pollock J Comput Biol. 2007 Nov;14(9):1176-84

“Gene expression profiling of the human prostate zones.” Ragavan N, Martin FL

BJU Int. 2007 Jan;99 (1):212 ( Letters to Editor)

“An observational study of cancers among female partners of UK-resident prostate cancer patients.” Ragavan N, Grover PL, Balasubramanian SP, Hindley AC, Matanhelia S, Martin FL. Cancer Lett. 2006 Oct 8;242(1):88-94

“Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell”

German MJ, Hammiche A, Ragavan N, Tobin MJ, Cooper LJ, Matanhelia

SS, Hindley AC, Nicholson CM, Fullwood NJ, Pollock HM, Martin FL. Biophys J. 2006 May;90(10):3783-95.

“A Randomised Controlled Trial comparing Lignocaine Peri-Prostatic Nerve Block (PPNB), Diclofenac suppository and both in Transrectal Ultrasound (TRUS) guided biopsy of prostate” N Ragavan, J Philip, SP Balasubramanium, J Desouza, C Marr, P Javle J Urol. 2005 Aug;174(2):510-13

“Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity” Morris JD, Pramanik R, Zhang X, Carey AM, Ragavan N, Martin FL, Muir GH

Cancer Lett. 2006 Jul 28;239(1):111-22

“Economic consequences of prostate and bladder cancer in the UK” VK Sangar*, N Ragavan*, SS Matanhelia, ME Watson, RA Blades (*Joint first authors) BJU Int. 2005; 95(1):59-63

“Is DRE essential for the follow up of Prostate cancer patients? Audit of 194 patients “ N Ragavan, VK Sangar, S Gupta, J Herdmann, SS Matanhelia, ME Watson,

RA Blades Biomed Central Urology .2005, 5:1 http://www.biomedcentral.com/bmcurol/

“CYP1B1 expression in prostate is higher in the peripheral than in the transition zone” N Ragavan, R Hewitt, LJ Cooper, KM Ashton, AC Hindley, CM Nicholson,

NJ Fullwood, SS Matanhelia, FL Martin. Cancer Letters 2004; 215: 69-78

http://www.biomedcentral.com/bmcurol/


12

“Impact of peripheral biopsies in maximising early prostate cancer detection in 8,10 or 12 core biopsy regimes” J Philip, N Ragavan, J DeSouza, CS Foster, P Javle

BJU Int. 2004; 93 (9): 1218-20

“Penile Metastases In The Presence Of Normal PSA Levels And Negative Bone Scan: A Case Report. “ N. Ragavan, P. Irwin: The Internet Journal of Urology. 2004. Volume 2

Number 1

http://www.ispub.com/ostia/index.php?xmlFilePath=journals/iju/vol2n1/penile.xml

Publications as a collaborator

Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG etal Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. Br J Cancer. 2016 Apr 12;114(8):945-52.

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015 Oct 1;24(19):5589-602.

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Eeles RA et al Nat Genet. 2009 Oct;41(10):1116-21.

Multiple loci on 8q24 associated with prostate cancer susceptibility. Eeles RA et al Nat Genet. 2009 Oct;41(10):1058-60.

Abstracts

Day Case Lap Nephrectomy – safety and feasibility – TAPASUCON 2018

PSM in Radical prostatectomy – Open versus Robotic technique TAPASUCON 2018

Radical Nephrectomy with IVC thrombectomy – 5 year experience , USICON 2018

Modified Brickers anastomosis for Ileal conduit diversion – point of technique , USICON 2018

Extraperitoneal Robot assisted uretric tumour excision and reimplant- case report . USICON 2018

Does Extrapritoneal robotic prostatectomy favour early bowel recovery. N.Ragavan, USICON 2017




13

Outcomes of Robotic Partial Nephrectomy for T1b/ T2 RCC . N. Ragavan USICON 2017

Germ cell tumour of the kidney - Case report . N Ragavan USICON 2016 Vol 32 , Suppl 1

Robot Assisted Laparoscopic excision of Organ of Zuckerkandl . N Ragavan USICON 2016 Vol 32 , Suppl 1

Robot Assisted Lap excision of Intra Renal tumour – Role of Intraoperative ultrasound . N Ragavan USICON 2016 Vol 32 , Suppl 1

Renal Plasmacytoma – Case report . N Ragavan , Gyvi Gaurav USICON 2015, IJU supplements

Leipzig Bradford Technique of Robotic Radical Prostatectomy USICON 2014. N Ragavan , S Addla, JU Stolzenburg , IJU Supplements1 Vol 30

Total Intracorporeal Nephrouretrectomy . USICON 2014. N Ragavan. , IJU Supplements

Long term outcomes of AUS in children with Neuropathic bladders Surange R, Ragavan N, Baird A. Eur urol Supplements 2010.

Molecular and optical profiling of prostate tissues derived from populations with differential risk of prostate adenocarcinoma. PB Singh, II Patel, N Ragavan, SS Matanhelia, FL Martin.

BAUS section of Oncology meeting , 2009. BJMSU 2009

Gene expression of Phase I and Phase II metabolizing enzymes and PAH- DNA adduct formation in human prostate as risk factors in prostate cancer etiology Kaarthik John, Paras B. Singh, M. Margaret Pratt, Narasimhan Ragavan,

Katherine C. Cole, Shyam S. Matanhelia, David H. Phillips, Miriam C. Poirier, Francis L. Martin

EMS 38th Annual meeting 2008 , Abstract book ; 557

Immunohistochemical Determination and Comparison of Polycyclic Aromatic Hydrocarbon (PAH)-DNA Adduct Levels in Peripheral and Transition Zones of Human Prostate M. Margaret Pratt, Kaarthik John, Paul Sirajuddin, Narasimhan Ragavan, Francis L. Martin, Ofelia A. Olivero and Miriam C. Poirier EMS 2007

Pratt MM, Sirajuddin P, Castle PE, Phillips DH, Afework S , MacLean AB,

Ragavan N, Martin FL, Olivero OA, Poirier MC

Imaging and semiquantitation of polycyclic aromatic hydrocarbon (PAH)-DNA

adducts in human reproductive tissues.

Environmental and molecular mutagenesis, 47 (6): 475-475 Jul 2006


14

Prostate tissues for research - the way we do it N Ragavan, CM Nicholson, SS Matanhelia, FL Martin BPG abstract book (Prostate cancer and Prostatic diseases)

Vasovasotomy- A simpler way ! Ragavan N, Matanhelia M, Matanhelia S

BJUI suppl, 2006;97:72 (Abstract 90)

Wardill’s test – a useful predictor of voiding flow following removal of urinary catheter. J Philip, A Samsudin, N Ragavan, SR Stubington.

BJUI suppl, 2006; 97:78 (Abstract 102)

An observational study of cancers among female partners of UK-resident prostate cancer patients Ragavan N, Grover P, Balasubramanian SP, Hindley AC, Matanhelia SS,

Martin FL. Eur Urol Suppl 2006;5(2):165

Expression of hormone-/carcinogen-metabolising enzymes in the prostate: clues into peripheral-zone susceptibility? Ragavan N, Hewitt R, Hindley AC, Nicholson CM, Matanhelia SS, Martin FL

Eur Urol Suppl 2006;5(2):165

Imaging and semiquantitation of polycyclic aromatic hydrocarbon (PAH)-DNA adducts in human cervix, vulva, placenta and prostate using immunohistochemistry (IHC) and the Automated Cellular Imaging System (ACIS) . M Pratt, P Sirajuddin, PE Castle, DH Phillips, S Afework, AB MacLean, N Ragavan, FL Martin, RJ Sram, DK Manchester, OA Olivero and MC Poirier. Abstract 2058 AACR Abstract book 2006; 486

A susceptibility-to-adenocarcinoma signature in prostate tissue using high-resolution synchrotron IR micro-spectroscopy.

German, M.J., Ragavan, N., Hammiche, A., Tobin, M., Pollock, H., and Martin, F.L. (2005) European Journal of Genetic Toxicology

Modernisation of Prostate Cancer Follow-up: Shifting paradigms The Nurse Specialist and the Role of DRE Ragavan N, Sangar VK, Gupta S, Matanhelia SS, Watson ME, Blades RA Prostate Cancer Prostatic Diseases 2005 (8) 385

Lignocaine Periprostatic nerve block (PPNB) – With or Without Rectal Diclofenac for Transrectal Prostatic biopsy. Randomised Controlled Trial N Ragavan, J Philip, J DeSouza, C Marr, P Javle. Prostate Cancer Prostatic Diseases 2005 (8) 395

Does diclofenac increase the bleeding complications after prostatic biopsy? N Ragavan, J Philip, J DeSouza, C Marr, P Javle. Prostate Cancer Prostatic Diseases 2005 (8) 395


15

Is DRE essential for the follow up of prostate cancer patients? A Prospective audit of 194 patients Ragavan N, Sangar V, Gupta S, Herdmann J, Matanhelia S, Watson M.

Eur Urol suppl 4 (2005);3:79

Economics of bladder cancer management in the UK; A case for further investment in research. N Ragavan, VK Sangar, SS Matanhelia, ME Watson, RA Blades.

Eur Urol suppl 4 (2005);3:162

CYP1B1 expression and peripheral-zone susceptibility to prostate adenocarcinoma: comparisons with other carcinogen/hormone-metabolising enzymes Francis L Martin, Narasimhan Ragavan, Rebecca Hewitt, Andrew C Hindley,

Caroline M Nicholson, Shyam S Matanhelia AACR abstract book. Page 162 March 2005

CYP1B1 expression is higher in the peripheral zone compared to the transition zone: a difference underlying zonal susceptibility to prostate adenocarcinoma? N Ragavan, R Hewitt, AC Hindley, CM Nicholson, SS Matanhelia, FL Martin

Prostate Cancer and Prostatic Diseases (2006) 9, 310-335

The Economic Consequences of Prostate Cancer in the UK N Ragavan, VK Sangar, SS Matanhelia, ME Watson, RA Blades

Prostate Cancer and Prostatic Diseases (2006) 9, 310-335

Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma N Ragavan, R Hewitt, AC Hindley, CM Nicholson, SS Matanhelia, FL Martin

Mutagenesis.2004;19(6):503 (Abstract 13)

Pre-existing Levels of CYP1B1 Expression in Human Prostate Tissues

Modulated by 17-Oestradiol in the Presence of Benzo[a]pyrene Martin FL, Ragavan N, Hewitt R, Nicholson, CM, Matanhelia SS, Hindley AC, McMillan TJ. AACR abstract book. Page 95 March 2004.

Rectal Diclofenac along with periprostatic nerve block provides sustained pain relief after TRUS Biopsy N Ragavan, J Desouza, P Javle .

Euro Urology suppl 2(2003): 1:106.

Orthotopic neobladder vs. Ileal conduit diversion - A quality of life based comparison Philip J, Ragavan N, DeSouza J, Owen DA, Javle P J Urol 2004 .171; No 4, (Supplement): 15 Abstract no 57.


16

PRESENTATIONS Oral presentations

Current status of Intravesical therapy in NIMBC. HS Bhatt Oration, Coimbatore Nov 2017

Subtelities and nuances in the management of small renal masses. SZUSICON, Manipal, 2017

Extra peritoneal vs. Transperitoneal robotic radical prostatectomy – Single surgeons exerience . SZUSICON, Pondy, 2016.

Advanced Prostate Cancer – way forward . Pondy renal sciences club – Pondicherry – June 2016

Management advanced prostate cancer. Madras Urological Society. May 2016

Robotics in Prostate Cancer Tiruchi Oncology club Jan 2015

Robot assisted excision of organ of Zuckerkandl – USICON 2016

Robot assisted excision of intrarenal tumour with ultrasound guidance – USICON 2016

Germ cell tumour of kidney – USICON 2016

Asymptomatic men with low grade prostate cancer – management – second opinion debate . Prof HS Bhat Oration , Managalore Nov 2015

Extraperitoneal Robot assisted Laparascopic radical prostatectomy , TAPASU 2015 , Pondicherry

Robotic excision of Organ of Zuckerkandl – Case report , TAPASU 2015

Germ cell tumour of the kidney , Case report TAPASU 2015

Robotic excision of complete intra renal tumour , Robotic council of India , AIMS , Kochi Sept 2015

Radical Prosatetctomy in high risk disease , AIMS , Kochi May 2015

Renal Plasmacytoma – Case report , USICON 2015,

Leipzig – Bradford Technique of Robotic Radical prostatectomy – USICON, Delhi Jan 2014

Total Intracorporeal Nephroureterectomy . USICON, Delhi Jan 2014


17

Leipzig – Bradford Technique of Robotic Radical prostatectomy – TAPASU , Tiruchi, Sep 2013

Open Vs Lap Vs Robotic Radical Prostatectomy – Single Surgeons experience - TAPASU , Tiruchi, Sep 2013

Total Intracorporeal Robotic Nephroureterectomy - TAPASU , Tiruchi, Sep 2013

The presenting features of Penile Carcinoma-In-Situ and response to treatment with topical 5-Flurouracil - Norman Gibbon Meeting , Liverpool Feb 2011

Bone scan as a screening tool for prostate cancer patients – Is it useful? Norman Gibbon Meeting , Liverpool Feb 2011(second author)

Intravesical injection of Botulinum toxin A in treatment of idiopatic detrusor overactivity: a review of 5 years’ activity. Norman Gibbon Meeting , Liverpool Feb 2011 (second author)

Early Feeding after cystectomy - ? A feasible option Normand Gibbon Meeting, Liverpool Feb 2010

An analysis of hormone- or carcinogen-metabolising enzyme expression in human prostate in relation to susceptibility to adenocarcinoma . Invited speaker, Biomedical conference . India, August 2009

Intra- , Inter-individual and Inter -Ethinic differences in the hormone- and carcinogen-metabolism in the prostate . NorthWest Urology meeting , Warrington , May 2009

Isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy has a high-risk association with prostate cancer: a UK hospital experience. Norman Gibbon Meeting , Liverpool , January 2008 ( second author)

Hormone- and carcinogen-metabolism in cancer-free prostate: peripheral- Vs. transition-zone differences in quantitative whole-tissue gene expression Norman Gibbon Meeting, Liverpool, January 2005

A susceptibility-to-adenocarcinoma signature in prostate tissue using high-resolution synchrotron IR micro-spectroscopy European Environemental Mutagensis Society (second author)

Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma. North West Trainees’ Research Meeting, Manchester, September 2004.


18

The role of chemical carcinogens in the etiology of prostate cancer. Annual Research Conference. LSCRN, Preston, September 2004.

Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma. UKEMS, Loughborough, July 2004.

Lignocaine Periprostatic nerve block (PPNB) – With or Without Rectal Diclofenac for Transrectal Prostatic biopsy. A Prospective Randomised Controlled Trial. BPG Meeting, London, March 2004.

Xenobiotic metabolism in the aetiology of prostate cancer. North West Trainees’ Research Meeting, Manchester, April 2004.

Economic consequences of prostate and bladder cancer. North West Trainees’ Research Meeting, Manchester, March 2003.

Leading towards nurse led prostate cancer follow up.North West Trainees’ Research Meeting, Manchester, March 2003.

Economic consequences of prostate and bladder cancer (Protocol) North West Trainees’ Research Meeting. Manchester, September 2002.

New bladder available at your local hospital. Liverpool and Northwest Surgeons Meeting, Liverpool, November 2001.

Combined oral and poster presentation

Loupe-assisted vasovasostomy with removable stent yields high patency rates. BAUS, Manchester, June 2006

An observational study of cancers among female partners of UK-resident prostate cancer patients EAU, Paris, April 2006

Expression of hormone-/carcinogen-metabolising enzymes in the prostate: clues into peripheral-zone susceptibility? EAU, Paris, April 2006

Is DRE essential for the follow up of prostate cancer patients? A Prospective audit of 194 patients

EAU, Istanbul, March 2005.

Economics of bladder cancer management in the UK; A case for further investment in research. EAU, Istanbul, March 2005.

Hormone- and carcinogen-metabolism in cancer-free prostate: peripheral- Vs. transition-zone differences in quantitative whole-tissue gene expression Urological research Society Meeting, London, January 2005.


19

CYP1B1 expression and peripheral-zone susceptibility to prostate adenocarcinoma: comparisons with other carcinogen/hormone-metabolising enzymes AACR 2005 ( Second author)

CYP1B1 expression is higher in the peripheral zone compared to the transition zone: a difference underlying zonal susceptibility to prostate adenocarcinoma? Prostate cancer - A meeting of minds (BPG), Manchester, November 2004.

Rectal Diclofenac along with periprostatic nerve block provides sustained pain relief after TRUS Biopsy. EAU conference, Madrid, March 2003


Modulated by 17-Oestradiol in the Presence of Benzo[a]pyrene. AACR, Florida, March 2004 (second author).

Orthotopic neobladder vs. Ileal conduit diversion - A quality of life based comparison. AUA, San-Francisco, May 2004 (second author).

Poster presentation

Prostate tissues for research - the way we do it BPG meeting – Cardiff, September 2006

CYP1B1 expression is higher in the peripheral zone compared to the transition zone: a difference underlying zonal susceptibility to prostate adenocarcinoma? Meeting of Minds (BPG) – Manchester, November 2004

The Economic Consequences of Prostate Cancer in the UK Meeting of Minds (BPG) – Manchester, November 2004


Modulated by 17-Oestradiol in the Presence of Benzo[a]pyrene. North West Cancer Research Foundation Meeting, Liverpool, May 2004.

Modernisation of Prostate Cancer Follow-up: Shifting paradigms The Nurse Specialist and the Role of DRE. BPG Meeting, London, March 2004

Does diclofenac increase the bleeding complications after prostatic biopsy? BPG Meeting, London, March 2004.


20

TRAINING VIDEOS

Laparoscopic Endoscopic Single site Surgery – Radical Nephrectomy

Laparoscopic Endoscopic Single site Surgery - Bladder diverticulectomy AUDIT EXPERIENCE Hospital audits

Radical Prostatectomy: Oncological and Functional Outcomes. It is rolling audit at BTHFT, retrospective in nature. This audit highlighted that our positive margin rate and complications were acceptable but there were higher proportion of patients with pT3 disease.

Radical Cystectomy: Early and Late Outcomes. Rolling audit with retrospective and prospective data collection. This audit concluded our morbidity and mortality rates were in line with world literature. Further, there was not much difference in morbidity and progression free survival with or without neoadjuvant chemotherapy.

Penile Carcinoma in Situ – Presenting features and treatment with 5FU Methods – Retrospective case notes analyses of 28 patients. Results – The treatments included circumcision + 5FU (11), radical circumcision (± local glans excision)(16) and radical circumcision and skin grafting(1). 8 patients (72.7 % ) complete response while 3 had incomplete response ( on repeat biopsy; CIS = 2, CIS with micro invasion = 1). At a mean follow up of 21.1 months 3 recurrences (2 in the 5FU non complete responders and 1 following radical circumcision) were noted. Conclusion - Treatment with topical 5 FU can be significantly painful. Failure to achieve complete response carries risk of previously undetected invasive cancer and of subsequent recurrences

Value of Frozen section (FZ) in patients undergoing penis preserving surgery Method – Retrospective analyses of database and case notes at Arrowe Park Hospital. Results – FZ was performed in 10/25 patients (40%), of which it was positive in 4/10 patients (40%). No recurrences were noted in 22 patients (88%) (Includes all patients who had positive FZ and further excision) while 1 (4%) patient had local recurrence (FZ negative) and 2(8%) had systemic recurrence (FZ negative =1 and FZ not taken =1) Recommendations - FZ is a valuable tool particularly, when used in selected circumstances as it would avoid further anaesthetic requiring completion of excision.

Audit on the outcomes of early feeding programme after cystectomy. Method – Retrospective and prospective analyses of the outcomes, and short term complications following early feeding programme after cystectomy


21

Results – The complications appears similar to delayed feeding. There is tendency of early discharge in patients

Role of bone scans in the contemporary management of prostate cancer patients Methods - Retrospective review of prostate cancer patients undergoing bone scan over 1 year period (June 07- May 08). Results - 166 patients underwent bone scans (new = 53, f/u = 113) with clear results in (142 (85.5 %) (positive for met s = 36, negative = 106). In 14.5% of patients (n=24) scan was equivocal requiring secondary assessment to clarify the outcome (negative = 16, positive = 6, inconclusive = 2). Conclusions - Bone scan is a useful tool but has limitations. Newer modalities (MR survey) could be considered for patients in future

Outcomes of diagnostic cystoscopies – When should we do? Method – Prospective data collection at flexible cystoscopies to assess their outcomes at Aintree Hospitals NHS Trust Results – 24% of haematuria patient had a significant finding in the Flexi including 12% had bladder tumour. However in non-haematuria patients only 2% had bladder tumour. While, Flexible cystoscopy was appropriate as a 1st line investigation in all patients presenting with haematuria, it was deemed so in 32% of Non-Haematuria patients. Recommendations – 1. One stop haematuria service was needed to streamline service. 2. Careful referral is required for patients without haematuria

Outcome of reversal of vasectomy – Leighton Hospital Method - Retrospective audit of all vaso-vasostomy done by single surgeon (2000-2006) combined with a simple questionnaire. Results – 6/7 patients who had semen analyses were positive for sperms . However only 2/11 patient achieved pregnancy by natural methods. Recommendations – Routine semen analyses 6-12 months after vasectomy reversal was recommended. This audit was also a useful tool in counselling future patients for the procedure

Audit of laparoscopic nephrectomy in children – Feasibility for the procedure to be done as a day case Method – Retrospective case note analysis at Alder Hey Children’s Hospital. Results – The operative and post operative recovery along with analgesics requirements were assessed in 44 patient who had Lap Nephrectomy. It emerged that majority of them were fit for discharge soon after the procedure. Recommendations - In majority of the children with no pre exiting medical ailments, Lap nephrectomy can be offered as a day case.

Audit of the Nurse led prostate cancer follow up clinic Method - Retrospective audit at Royal Preston Hospital. Results - 231 patients seen over 6 months. The factors influencing changes in the management were PSA trend (15), LUTS (7), bone pain (5), DRE alone –


22

nil. However DRE along with PSA influenced a change in the management in 6 patients Recommendations – Nurse led clinic run parallel to the consultant clinic with a protocol to do DRE if there is change in PSA or onset of new symptoms was effective.

The value of DRE and PSA in the follow up of patients with prostate cancer. Method - Prospective audit at Royal Preston Hospital. Results - 194 patients follow up was audited over 4 months. The factors influencing change in the management were PSA trend (27), LUTS (10), bone pain (4), DRE change (2) and others (4). Recommendations - The PSA trend is the most common factor influencing the change in the management. The audit influenced the initiation of nurse led prostate cancer follow up clinic in the hospital.

The immediate postoperative complications and recatheterisation rates after TURP. Method - Prospective audit of 50 patients over 4 months at Leighton Hospital Results - 22 % of patients had postoperative hematuria, 12 % had infection and 24 % of patients failed TWOC. Recommendations – Better case selection, rigid antiseptic measures and antibiotic cover during the procedures were decided to be implemented.

The value of C-reactive protein and WBC in acute abdomen at Caithness General Hospital. Method - Prospective audit of 66 patients over 6 months. Results - CRP did not have advantage over WBC measurement Recommendations - Practice of routine CRP measurements was stopped.

External duodenal fistula following surgery for ulcer perforation at Postgraduate Institute of Medical Education and Research (PGIMER). Method - Retrospective analysis of 13 patients treated over 5 years. Results - Mortality was 53.8 % and enteral nutrition was the corner stone of successful therapy. Recommendations - Change of the practice to more conservative management of such patients with enteral nutrition was adopted.

Regional audits

I collated the data on behalf of Arrowe Park Hospital for the North West regional audit on penile cancer - May 2010

I presented the literature review and acted as local expert for the North West Regional audit on Radical nephrectomy –Nov 2009

I collected the data on behalf of Leighton hospital for the North West regional audit on epidydimo orchitis, management of male infertility and management of erectile dysfunction. 2002


23

National Audit

I collated the data on behalf of Arrowe Park Hospital for National Penile cancer audit on patients with N2 and N3 disease. 2010

INVITED LECTURES I have given lectures in many medical and public forums including IMA,s, Rotary clubs, scientific meetings etc Few salient ones include

Robotics and Artificial Intelligience – Biomedical conference , Tiruchi Nov 2017

Intravesical Chemotherapy – HS Bhatt Oration . Coimbatore . Oct 2017

Robotic prostatectomy . High precision oncology meeting Kochi

Robotics in Urology –Global and Indian Scenario – RUFCON 2017

Point of technique and advantages of extra peritoneal robotic radical prostatetcomy. Karnataka Urology Association meet Goa Sept 2016

Radical prostatetcomy in high risk prostate cancer . Master class in Urooncology Kochi Sept 2016

Surgery in advanced prostate cancer . Masterclass in Urooncology Sept 2016 Kochi

HSBhat Oration – Nov 2015

Robotic council of India meeting 2015

Screening for prostate cancer – Mumbai 2014

Radical Prostatetcomy – TAPASU Urooncology meet – Tiruchi 2014

Radical Prostatetcomy Versus Radical Radiotherapy – Global Prostate Centre – Bangalore

Prostate Cancer – Nigerian Urology Association , Nigeria

Robotics – Railway Hospital, Chennai

POSTGRADUATE EDUCATION COURSES CONDUCTED

Critical care course for surgeons . Sept 2017 at Chennai , Dec 2017 at Coimbatore

Introduction to UroOncology – Oct 2017 , Chennai

Point Counter Point – Debates in Prostate Cancer – July 2018

Bladder cancer update April 2018 COURSES

Robotic Console surgeon training - Paris June 2012

Robotic Training day at UCL – London , Oct 2012

Management Course – Mersey Deanery July 2010


24

Wet lab course – Rotterdam Jun 2010

Masterclass in Pelvic Laparoscopy – Middlesbrough March 2010

Training the Trainers – Feb 2010

Developing medical leaders – Liverpool Oct 2009

FRCS Viva course – Oxford March 2009

Laparoscopy – Dry Lab course – Rhyl, March 2008

Green light Laser course – Rhyl , 2007

Leadership and management skills for SpR’s – Liverpool, Oct 2007

Spinal cord Injury Course - Sheffield, May 2007

Interview skills for SpR’s – Liverpool , April 2007

Renal failure course , Manchester , BAUS , June 2006

Renal Transplantation course , Manchester , BAUS , June 2006

Paediatric Urology course, Cambridge , September 2005

Ureteroscopy Skills Course, Harrogate, BAUS June 2004

Scientific basis of urology, London, December 2003

Statistical methods in health research, Lancaster, November 2003

Basic Laparoscopy, Manchester, BAUS June 2003

Ultrasound for urologist, Madrid, EAU March 2003

Practical skills for urological surgeons, London, November 2002

European computer driving license, Royal Preston Hospital

Advanced course on urodynamics, Manchester, April 2002

ATLS course, Coventry, June 2001

Introductory course on GIA staplers, PGIMER, April 1999


25

CONFERENCES AND MEETINGS

TAPASU 2018 Kodaikanal

USICON , Jaipur 2018

ICC Bangalore Dec 2017

SZUSICON July 2017

TAPASU August 2017

RUFCON Mumbai April2017

Apollo Cancer Conclav Hyderabad 2017

KUA – Goa 2016

Masterclass in Urooncology Kochi 2016

TAPASU Yercaud 2016

SZUSICON Pony 2016

USICON , Hyderabad, 2016

Prof HS Bhat oration Mangalore 2015

TAPASU Pondicherry 2015

SUZICON Vizag 2015

UroOncology meet – Amritha Institute , Kochi 2015

Urooncology workshop and meeting , Mumbai 2014

Midterm CME – TAPASU , Tiruchi 2014

USI 2014

TAPASU 2013

BAUS Annual conference Liverpool 2011

Norman Gibbon Meeting , Liverpool Feb 2005 – 2011

BAUS Annual Conference , Manchester June 2010, June 2008 , June 2006 and June 2003


26

BAUS section of Oncology meeting , Birmingham , Nov 2009

SURG ,Liverpool Sept 2009

New Frontiers in Biomedical Sciences , India , August 2009

BAUS Annual Conference, Glasgow, June 2009 and June 2007

British Prostate Group meeting, Cardiff, September 2006

BAUS Annual conference , Manchester , June 2006

Annual EAU conference , Paris , April 2006

Long term sequel of Inter sex disorders , RCOG, London Dec 2005

Annual EAU conference , Istanbul , March 2005

Urological Research Society meeting. London, January 2005

Meeting of Minds (BPG). Manchester, November 2004

UK Environmental Mutagen Society. Loughborough , July 2004

BAUS Annual conference. Harrogate, June 2004

British Prostate Group meeting. London, March 2004

Annual EAU conference. Madrid, March 2003

3rd North West Urology Group meeting. Manchester, November 2002

North West Trainees’ Research meeting. Manchester, September 2002, March 2003, September 2003, March 2004, September 2004

North West urology audit meeting. Manchester, March 2002

Liverpool and North West surgeons meeting. Liverpool, November 2001

TEACHING EXPERIENCE Postgraduate Certificate in Teaching and Learning in Clinical practice.

I have a liking for teaching and therefore take special interest. I have completed the postgraduate certificate in teaching and learning and apply it in day to day practice


27

I have done lectures for medical students as well as non medical students (BSc students at Lancaster University). I have also done – one-one teaching, small group discussion and bedside teaching I also actively train my juniors’ in general clinical and operative practice. I have devised a rota / micro curriculum for medical students incorporating the learning objectives (corresponding to their year of training). I played an active role in revising the curriculum for undergraduate students I have compiled a “Urology Pack” for FY and ST Doctors. I also take an active role in improving my own teaching skills and therefore obtain feedback from the taught group. I have taken an active part in the revision of urology curriculum for undergraduate students at Liverpool Medical School. I am a trainer and thesis guide for DNB urology programme I am an examiner for MRCS exams

TEAM WORKING My role of team leader I was the STEC representative and regional teaching coordinator. I lead by example of dedication and enthusiasm. I appropriately delegate topics prioritising the training needs. I engaged in a consultation process involving the trainees and trainers demonstrating my inclusive leadership trait. I have also devised an evaluation form to improve performance based on feed-back My role as a team player This is best highlighted at Specialist MDT meetings. As a consultant, I not only highlight the salient clinico-radiological findings but also streamline investigations and management care plans in coordination with specialist nurses. This ensures and facilitates seamless discussions in MDT forums focusing on optimising patient outcomes. As a keen team player, I also follow up on these care plans and ensure timely implementation.

MANAGEMENT

I have revised clinical pathways at BTHFT; TRUS pathway, cancer pathways and TWOC pathways.I was also the audit lead during my tenure at BTHFT. Previously, I had actively involved in streamlining the work in the local hospitals. I have therefore devised Urology Pack for FY and ST doctors, Rota / Micro-curriculum for Medical Students and devised a proforma for reporting Urodynamic studies.


28

I was an elected member of the “Doctors Mess” at the Medical school. The role involves active liaising with other members of the group as well as the students and the accommodation officers, plan out strategies for effective utilization of resources and ensure harmony in the working atmosphere.

I have worked closely with my consultants and have helped to initiate mortality and morbidity meeting in Aintree as well as at Royal Liverpool Hospital

MEMBERSHIP OF LEARNED SOCIETIES

British Association of Urological Surgeons

European Association of Urology

BAUS section of Oncology

USI

ASU

TAPASU

IT SKILLS I am well versed with windows operating systems and its applications. I have completed ECDL certification course.

PERSONAL ATTRIBUTES, HOBBIES AND INTERESTS

I am a person and who can make friends easily. I respect all the members of my team including my colleagues, secretarial, nursing and ancillary staff understanding their individual contributions to the patient care and the smooth functioning of the NHS.

At work, I believe in dedication and sincerity, with patients at the center of the care we provide. I am willing to step in and support my colleagues and staff at the time of need and difficulties

Outside hospital, I believe in my personal space and my contribution to my family.

I have varied interests including hill walking, jogging and listening to music.

I believe in keeping fit and I jog 2 miles a day.

My avidity to explore nature has encouraged me to travel far and wide.

CAREER OBJECTIVE My clinical interests are Uro-Oncology and General Urology. My research interests lies in the management of urological cancers especially prostate I believe in training and clinical education as an integral part of practice and would like to actively be involved in both undergraduate and postgraduate education.

Documents

DATE OF BIRTHGold medal in surgery-1993, SRMC, India. Gold medal in anatomy-1990, SRMC, India. Honours in Anatomy, Physiology and Biochemistry In the University and College examinations